Ocrelizumab Shows First Signs of Promise for Patients with Primary Progressive Multiple Sclerosis
In this video by MD Magazine TV, learn more about the first signs of promise for patients with primary progressive multiple sclerosis.
Even as more medications are developed for relapsing-remitting multiple sclerosis patients, those with the primary progressive form have been left waiting for news on their condition.
According to recent studies, the first step in that process may soon be coming to the market.
Learn more about Ocrelizumab for primary progressive multiple sclerosis here: http://bit.ly/1JUBLqj